Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

138.55
-1.2200-0.87%
Post-market: 138.790.2400+0.17%19:18 EDT
Volume:3.43M
Turnover:475.84M
Market Cap:171.90B
PE:20.44
High:140.27
Open:138.61
Low:137.75
Close:139.77
52wk High:157.29
52wk Low:93.37
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.72
T/O Rate:0.28%
Dividend:3.16
Dividend Rate:2.28%
EPS(TTM):6.78
EPS(LYR):6.78
ROE:40.66%
ROA:12.52%
PB:7.57
PE(LYR):20.44

Loading ...

Sector Update: Health Care

MT Newswires Live
·
Apr 08

Dow Jones Top Company Headlines at 1 PM ET: Intel Partners With SpaceX, Tesla to Operate New Chip Plant | Bill ...

Dow Jones
·
Apr 08

Gilead to acquire Tubulis for $3.15B upfront, up to $1.85B in milestone payments

TIPRANKS
·
Apr 07

Gilead Buying Another Cancer-Drug Partner -- Market Talk

Dow Jones
·
Apr 07

Deals of the day-Mergers and acquisitions

Reuters
·
Apr 07

Gilead Sciences Shares Slip 1.2% After Co to Buy Germany's Tubulis for up to $5 Bln

THOMSON REUTERS
·
Apr 07

Gilead Sciences Invests $5 Billion in ADC Sector with Acquisition of Germany's Tubulis

Stock News
·
Apr 07

RBC Adjusts Price Target on Gilead Sciences to $123 From $118, Maintains Sector Perform Rating

MT Newswires Live
·
Apr 07

Gilead to buy Tubulis for USD 3.15 billion upfront, adds next-generation ADC platform

Reuters
·
Apr 07

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline

THOMSON REUTERS
·
Apr 07

BRIEF-Gilead Sciences To Acquire Tubulis GmbH

Reuters
·
Apr 07

Gilead Sciences: to Acquire Tubulis Gmbh

THOMSON REUTERS
·
Apr 07

Gilead Sciences: Deal Includes up to $1.85 Bln in Contingent Milestone Payments

THOMSON REUTERS
·
Apr 07

Gilead Sciences: Will Acquire All of Outstanding Equity of Tubulis for $3.15 Bln in Upfront Cash Consideration on Cash-Free, Debt-Free Basis

THOMSON REUTERS
·
Apr 07

Gilead Sciences: Plans to Finance Deal With Combination of Cash on Hand & Senior Unsecured Notes

THOMSON REUTERS
·
Apr 07

Gilead Agrees to Buy Cancer Biotech Tubulis in $5 Billion Deal - Bloomberg News

THOMSON REUTERS
·
Apr 07

Gilead Will Pay $3.15 Billion Upfront in Cash, and up to $1.85 Billion More IF Tubulis Meets Certain Milestones - Bloomberg News

THOMSON REUTERS
·
Apr 07

Market Chatter: Gilead Sciences to Buy Tubulis for Up to $5 Billion

MT Newswires Live
·
Apr 07

Gilead Sciences to Buy Tubulis for Up to $5 Billion, Bloomberg Reports

MT Newswires Live
·
Apr 07

Gilead Sciences (GILD) Receives a Buy from Bernstein

TIPRANKS
·
Apr 06